DIMETHYL SULFOXIDE

DIMETHYL SULFOXIDE was reported 243 times

DIMETHYL SULFOXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRIGEMINO-CARDIAC REFLEX 8 0.0988
1 NEURON-SPECIFIC ENOLASE INCREASED 1 0.0909
2 VAGINAL FLATULENCE 22 0.0726
3 TRACHEAL COMPRESSION 3 0.0652
4 LIVING ALONE 1 0.0333
5 SMALL AIRWAYS DISEASE 2 0.0220
6 MUCOPOLYSACCHARIDOSIS II 1 0.0213
7 URETHRAL DILATATION 1 0.0164
8 PITUITARY-DEPENDENT CUSHING'S SYNDROME 1 0.0152
9 FEMALE GENITAL TRACT FISTULA 23 0.0135
10 AMMONIA DECREASED 1 0.0128
11 OUT OF SPECIFICATION TEST RESULTS 1 0.0100
12 JOINT PROSTHESIS USER 1 0.0100
13 CATHETER SITE INJURY 2 0.0094
14 RADICULOPATHY 22 0.0083
15 PROCTITIS 22 0.0078
16 PH BODY FLUID ABNORMAL 1 0.0072
17 CHRONIC SINUSITIS 24 0.0064
18 URINARY BLADDER SUSPENSION 1 0.0061
19 HYPERTROPHY 3 0.0055
20 POST PROCEDURAL PAIN 1 0.0054
21 SALT CRAVING 1 0.0048
22 PENILE BLISTER 1 0.0047
23 AMYLOIDOSIS 8 0.0046
24 BLOOD IRON ABNORMAL 4 0.0041
25 FACIAL NEURALGIA 1 0.0038
26 SCROTAL ULCER 1 0.0038
27 NEPHROSCLEROSIS 4 0.0036
28 DERMAL ABSORPTION IMPAIRED 1 0.0036
29 PENILE ULCERATION 1 0.0031
30 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
31 EAR CONGESTION 8 0.0029
32 BENIGN NEOPLASM 3 0.0027
33 CAPILLARY DISORDER 1 0.0026
34 RETINAL PIGMENTATION 2 0.0025
35 CYSTITIS INTERSTITIAL 4 0.0025
36 LARYNGEAL PAIN 1 0.0025
37 ALVEOLAR OSTEITIS 1 0.0024
38 OROPHARYNGEAL SPASM 1 0.0024
39 COLONOSCOPY ABNORMAL 1 0.0023
40 RETICULOCYTE COUNT DECREASED 1 0.0023
41 PNEUMATOSIS 1 0.0022
42 HAEMORRHOID OPERATION 1 0.0022
43 VAGINAL DISCHARGE 22 0.0022
44 URINARY TRACT DISCOMFORT 1 0.0022
45 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
46 MACULAR DEGENERATION 25 0.0021
47 THERAPEUTIC REACTION TIME DECREASED 6 0.0021
48 SPINAL LAMINECTOMY 2 0.0020
49 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
50 RETROGRADE AMNESIA 1 0.0020
51 ORAL CANDIDIASIS 24 0.0018
52 RESPIRATORY DEPRESSION 22 0.0018
53 PARAESTHESIA ORAL 25 0.0017
54 URETHRAL PAIN 1 0.0017
55 BLADDER PAIN 5 0.0016
56 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
57 ACCIDENTAL POISONING 2 0.0015
58 ANTIBODY TEST ABNORMAL 1 0.0014
59 BRAIN STEM SYNDROME 1 0.0013
60 BREAST FEEDING 1 0.0013
61 BLOOD BLISTER 4 0.0013
62 PROCTALGIA 8 0.0012
63 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
64 BRONCHIOLITIS 4 0.0011
65 BLOOD MAGNESIUM INCREASED 1 0.0011
66 EXTENSOR PLANTAR RESPONSE 1 0.0011
67 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
68 SKIN GRAFT 1 0.0011
69 APHTHOUS ULCER 8 0.0010
70 BRAIN OEDEMA 13 0.0010
71 ANIMAL SCRATCH 1 0.0010
72 EPIDERMAL NECROSIS 1 0.0010
73 PRINZMETAL ANGINA 1 0.0010
74 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
75 PERIPHERAL VENOUS DISEASE 4 0.0010
76 RETINAL TOXICITY 1 0.0010
77 BLAST CELL COUNT INCREASED 1 0.0010
78 ASTERIXIS 1 0.0009
79 HYDROCELE 1 0.0009
80 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
81 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
82 STRESS AT WORK 1 0.0009
83 BLOOD FIBRINOGEN DECREASED 1 0.0009
84 CARBON DIOXIDE DECREASED 1 0.0009
85 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
86 PROCEDURAL PAIN 24 0.0009
87 PROCALCITONIN INCREASED 1 0.0009
88 FREQUENT BOWEL MOVEMENTS 23 0.0009
89 BILE DUCT CANCER 1 0.0008
90 BREATH ODOUR 2 0.0008
91 PENILE SWELLING 1 0.0008
92 BLOOD UREA DECREASED 1 0.0008
93 BLADDER DISCOMFORT 1 0.0008
94 GASTROINTESTINAL INFLAMMATION 6 0.0008
95 ANION GAP INCREASED 1 0.0007
96 ANAL FISSURE 4 0.0007
97 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
98 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
99 TONIC CONVULSION 1 0.0007
100 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
101 IMMOBILE 3 0.0007
102 BRAIN HERNIATION 2 0.0007
103 BONE MARROW DISORDER 2 0.0007
104 CALCULUS URINARY 1 0.0006
105 BRAIN DEATH 2 0.0006
106 ARTERIOSCLEROSIS 6 0.0006
107 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
108 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
109 SPLENIC RUPTURE 1 0.0006
110 COLITIS 23 0.0006
111 GAZE PALSY 1 0.0006
112 NEUTROPHIL COUNT INCREASED 6 0.0006
113 HYPERLIPIDAEMIA 7 0.0006
114 BLOOD AMYLASE INCREASED 1 0.0006
115 BLOOD CHLORIDE INCREASED 1 0.0006
116 NECROTISING FASCIITIS 2 0.0006
117 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
118 OESOPHAGEAL SPASM 1 0.0005
119 ACCIDENTAL DEATH 1 0.0005
120 RECTAL HAEMORRHAGE 23 0.0005
121 TUNNEL VISION 1 0.0005
122 BLADDER SPASM 1 0.0005
123 BLOOD IRON INCREASED 1 0.0005
124 PROTEIN TOTAL DECREASED 2 0.0005
125 PULMONARY CONGESTION 7 0.0005
126 PARANASAL SINUS DISCOMFORT 2 0.0005
127 COLITIS ULCERATIVE 23 0.0005
128 WOUND SECRETION 2 0.0005
129 VOCAL CORD DISORDER 1 0.0005
130 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
131 MUSCLE DISORDER 4 0.0005
132 CHOLANGITIS SCLEROSING 1 0.0005
133 QUADRIPLEGIA 1 0.0005
134 SCOLIOSIS 3 0.0005
135 CAPILLARY LEAK SYNDROME 1 0.0005
136 OLIGURIA 3 0.0005
137 HEPATIC PAIN 2 0.0005
138 VITAMIN D DECREASED 4 0.0005
139 BLOOD TESTOSTERONE INCREASED 1 0.0005
140 VITREOUS DETACHMENT 1 0.0005
141 OSTEOPENIA 7 0.0005
142 HAEMATOCHEZIA 24 0.0004
143 NEUROLOGICAL DECOMPENSATION 1 0.0004
144 SINUS PAIN 1 0.0004
145 PRURITUS GENITAL 1 0.0004
146 BLOOD IRON DECREASED 5 0.0004
147 SLEEP APNOEA SYNDROME 8 0.0004
148 URINE FLOW DECREASED 1 0.0004
149 INFUSION RELATED REACTION 27 0.0004
150 INJECTION SITE EXTRAVASATION 5 0.0004
151 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
152 STEM CELL TRANSPLANT 1 0.0004
153 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
154 ABDOMINAL INFECTION 1 0.0004
155 INCONTINENCE 4 0.0004
156 HEPATIC STEATOSIS 7 0.0004
157 YAWNING 1 0.0004
158 CLONUS 1 0.0004
159 INTRACRANIAL PRESSURE INCREASED 2 0.0004
160 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
161 PNEUMATOSIS INTESTINALIS 1 0.0004
162 CARDIOTOXICITY 3 0.0003
163 PENILE PAIN 1 0.0003
164 IRRITABLE BOWEL SYNDROME 7 0.0003
165 LIVER FUNCTION TEST INCREASED 7 0.0003
166 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
167 LIMB DISCOMFORT 10 0.0003
168 HEPATIC CIRRHOSIS 6 0.0003
169 BLOOD CREATININE DECREASED 1 0.0003
170 TESTICULAR PAIN 1 0.0003
171 POLYMYALGIA RHEUMATICA 1 0.0003
172 EXPOSURE TO TOXIC AGENT 1 0.0003
173 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
174 PRODUCT LABEL ISSUE 2 0.0003
175 WOUND COMPLICATION 1 0.0003
176 DYSPEPSIA 28 0.0003
177 MACULOPATHY 1 0.0003
178 ABDOMINAL PAIN LOWER 7 0.0003
179 MONOCYTE COUNT INCREASED 1 0.0003
180 BLOOD PHOSPHORUS DECREASED 1 0.0003
181 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
182 SKIN HAEMORRHAGE 4 0.0003
183 MUSCULOSKELETAL DISORDER 5 0.0003
184 FAECES HARD 1 0.0003
185 RHINOVIRUS INFECTION 1 0.0003
186 SKIN ODOUR ABNORMAL 1 0.0003
187 DRUG SCREEN POSITIVE 2 0.0003
188 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
189 PULMONARY OEDEMA 11 0.0002
190 SPINAL STENOSIS 1 0.0002
191 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
192 SUICIDAL BEHAVIOUR 1 0.0002
193 ACCIDENTAL EXPOSURE 1 0.0002
194 TONGUE DISCOMFORT 1 0.0002
195 JOINT INJURY 5 0.0002
196 SHOULDER OPERATION 1 0.0002
197 SCAR 4 0.0002
198 ROTATOR CUFF SYNDROME 3 0.0002
199 SPINAL OSTEOARTHRITIS 2 0.0002
200 VULVOVAGINAL DISCOMFORT 1 0.0002
201 BLOOD CREATINE INCREASED 1 0.0002
202 ILEUS PARALYTIC 1 0.0002
203 CATARACT 13 0.0002
204 LYMPHOPENIA 3 0.0002
205 PULSE ABSENT 1 0.0002
206 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
207 FAECAL INCONTINENCE 1 0.0002
208 SINUS BRADYCARDIA 2 0.0002
209 RENAL CELL CARCINOMA 1 0.0002
210 NASAL POLYPS 1 0.0002
211 DIABETIC NEUROPATHY 1 0.0002
212 SALIVARY HYPERSECRETION 2 0.0002
213 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
214 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
215 HAEMATEMESIS 5 0.0002
216 DIABETES MELLITUS 15 0.0002
217 TINNITUS 9 0.0002
218 CACHEXIA 1 0.0002
219 PETECHIAE 2 0.0002
220 TONSILLITIS 1 0.0002
221 HEPATIC ENZYME INCREASED 13 0.0002
222 SERUM FERRITIN INCREASED 1 0.0002
223 ANORECTAL DISCOMFORT 1 0.0002
224 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
225 RASH PAPULAR 4 0.0002
226 ANGIOPATHY 1 0.0002
227 PRODUCT LEAKAGE 1 0.0002
228 FLUID RETENTION 9 0.0002
229 ABDOMINAL PAIN 41 0.0002
230 MOUTH SWELLING 1 0.0002
231 RALES 1 0.0002
232 NASAL CONGESTION 10 0.0002
233 PROTHROMBIN TIME PROLONGED 1 0.0002
234 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
235 NASAL DRYNESS 1 0.0002
236 HOT FLUSH 12 0.0002
237 MUSCLE ATROPHY 2 0.0002
238 JOINT STIFFNESS 4 0.0002
239 PRODUCT FORMULATION ISSUE 1 0.0002
240 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
241 UPPER LIMB FRACTURE 3 0.0002
242 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
243 PRODUCT ADMINISTRATION ERROR 3 0.0001
244 BRONCHIECTASIS 1 0.0001
245 TASTE DISORDER 3 0.0001
246 TACHYPNOEA 2 0.0001
247 BLOOD TESTOSTERONE DECREASED 1 0.0001
248 INFLUENZA LIKE ILLNESS 12 0.0001
249 CARDIAC ARREST 12 0.0001
250 DRUG INTERACTION 23 0.0001
251 POLLAKIURIA 6 0.0001
252 FEELING COLD 4 0.0001
253 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
254 TONGUE DISORDER 1 0.0001
255 HYPOKINESIA 2 0.0001
256 BLINDNESS TRANSIENT 1 0.0001
257 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
258 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
259 PAROSMIA 1 0.0001
260 BRADYCARDIA 7 0.0001
261 HAEMODYNAMIC INSTABILITY 1 0.0001
262 ANAEMIA 25 0.0001
263 RENAL IMPAIRMENT 11 0.0001
264 INSURANCE ISSUE 2 0.0001
265 MUSCULOSKELETAL CHEST PAIN 2 0.0001
266 EJECTION FRACTION DECREASED 2 0.0001
267 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
268 NASAL DISCOMFORT 1 0.0001
269 BLOOD ALBUMIN DECREASED 1 0.0001
270 UTERINE CANCER 1 0.0001
271 CONSTIPATION 27 0.0001
272 FLATULENCE 7 0.0001
273 SUBSTANCE ABUSE 1 0.0001
274 DECUBITUS ULCER 1 0.0001
275 ABNORMAL FAECES 1 0.0001
276 ERYTHEMA 25 0.0001
277 VENTRICULAR TACHYCARDIA 2 0.0001
278 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
279 COAGULOPATHY 2 0.0001
280 EOSINOPHIL COUNT INCREASED 1 0.0001
281 TOXICITY TO VARIOUS AGENTS 20 0.0001
282 CANDIDA INFECTION 2 0.0001
283 PSEUDOMONAS INFECTION 1 0.0001
284 MYOPATHY 1 0.0001
285 HYSTERECTOMY 1 0.0001
286 PYELONEPHRITIS 1 0.0001
287 ABDOMINAL DISTENSION 12 0.0001
288 PYREXIA 39 0.0001
289 MEDICATION ERROR 6 0.0001
290 SWELLING FACE 7 0.0001
291 SQUAMOUS CELL CARCINOMA 1 0.0001
292 SPUTUM DISCOLOURED 1 0.0001
293 BLOOD PRESSURE DECREASED 7 0.0001
294 MIGRAINE 10 0.0001
295 ERUCTATION 2 0.0001
296 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
297 HEPATOMEGALY 1 0.0001
298 BODY TEMPERATURE DECREASED 1 0.0001
299 INABILITY TO AFFORD MEDICATION 1 0.0001
300 BRAIN INJURY 1 0.0001
301 CYTOKINE RELEASE SYNDROME 2 0.0001
302 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
303 BODY TEMPERATURE INCREASED 2 0.0001
304 TEMPERATURE INTOLERANCE 1 0.0001
305 VENTRICULAR EXTRASYSTOLES 1 0.0001
306 TENDERNESS 1 0.0001
307 NERVOUSNESS 5 0.0001
308 RENAL PAIN 1 0.0001
309 BODY HEIGHT DECREASED 1 0.0001
310 WEIGHT DECREASED 26 0.0001
311 HYPOACUSIS 4 0.0001
312 POOR QUALITY SLEEP 2 0.0001
313 SKIN LACERATION 1 0.0001
314 PULMONARY THROMBOSIS 1 0.0001
315 FEBRILE NEUTROPENIA 6 0.0001
316 EXPIRED PRODUCT ADMINISTERED 3 0.0001
317 VENTRICULAR FIBRILLATION 1 0.0001
318 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
319 HYPERTENSIVE CRISIS 1 0.0001
320 NECK PAIN 5 0.0001
321 BLOOD CALCIUM DECREASED 1 0.0001
322 MICTURITION URGENCY 1 0.0001
323 MYOCARDITIS 1 0.0001
324 HYPOKALAEMIA 4 0.0001
325 EYELID OEDEMA 1 0.0001
326 SPINAL PAIN 1 0.0001
327 LYMPHADENOPATHY 3 0.0001
328 PERIPHERAL SWELLING 13 0.0001
329 MUSCLE RIGIDITY 1 0.0001
330 POLYNEUROPATHY 1 0.0001
331 WRIST FRACTURE 1 0.0001
332 NOCTURIA 1 0.0001
333 CARDIOMEGALY 1 0.0001
334 INFLUENZA 9 0.0001
335 DRY EYE 4 0.0001
336 SECRETION DISCHARGE 1 0.0001
337 SOMNOLENCE 16 0.0001
338 MYDRIASIS 1 0.0001
339 ANAPHYLACTIC SHOCK 2 0.0001
340 HEADACHE 48 0.0001
341 MUCOSAL INFLAMMATION 2 0.0001
342 BEDRIDDEN 1 0.0001
343 SINUS CONGESTION 1 0.0001
344 RASH PRURITIC 4 0.0001
345 LIMB INJURY 2 0.0001
346 RESPIRATORY ARREST 2 0.0001
347 OXYGEN SATURATION DECREASED 4 0.0001
348 DEVICE OCCLUSION 1 0.0001
349 SINUS TACHYCARDIA 1 0.0001
350 LOSS OF CONSCIOUSNESS 9 0.0001
351 HYPERHIDROSIS 9 0.0001
352 LETHARGY 4 0.0001
353 INTENTIONAL PRODUCT MISUSE 6 0.0001
354 URINARY INCONTINENCE 2 0.0001
355 IMMUNODEFICIENCY 1 0.0001
356 THROAT IRRITATION 3 0.0001
357 RESPIRATORY DISORDER 2 0.0001
358 HYPOAESTHESIA ORAL 1 0.0001
359 EPILEPSY 2 0.0001
360 DRUG ADMINISTRATION ERROR 2 0.0001
361 THYROID DISORDER 1 0.0001
362 ANKLE FRACTURE 1 0.0001
363 TENDONITIS 1 0.0001
364 NERVOUS SYSTEM DISORDER 2 0.0001
365 SWOLLEN TONGUE 2 0.0001
366 PAIN 39 0.0001
367 RESPIRATORY TRACT CONGESTION 1 0.0001
368 NIGHT SWEATS 2 0.0001
369 MALAISE 27 0.0001
370 NAUSEA 48 0.0001
371 PHOTOSENSITIVITY REACTION 1 0.0001
372 LEUKOPENIA 3 0.0001
373 URINARY RETENTION 2 0.0001
374 PALPITATIONS 7 0.0001
375 PERICARDITIS 1 0.0001
376 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
377 HAEMATURIA 2 0.0001
378 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
379 GASTRIC DISORDER 2 0.0001
380 PARANOIA 1 0.0001
381 OEDEMA PERIPHERAL 7 0.0001
382 DEVICE USE ISSUE 1 0.0001
383 MUSCULOSKELETAL STIFFNESS 5 0.0001
384 NEUROTOXICITY 1 0.0001
385 BURNING SENSATION 4 0.0001
386 HYPOXIA 2 0.0001
387 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
388 LYMPHOCYTE COUNT DECREASED 1 0.0001
389 TACHYCARDIA 5 0.0001
390 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
391 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
392 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
393 PELVIC PAIN 1 0.0001
394 DYSURIA 2 0.0001
395 ANAPHYLACTIC REACTION 3 0.0001
396 BRONCHITIS 4 0.0001
397 OROPHARYNGEAL PAIN 5 0.0001
398 COUGH 15 0.0001
399 BLOOD SODIUM DECREASED 1 0.0001
400 MUSCULAR WEAKNESS 6 0.0001
401 BLOOD URINE PRESENT 1 0.0001
402 DEHYDRATION 7 0.0001
403 FEELING JITTERY 1 0.0001
404 BLOOD PRESSURE INCREASED 8 0.0001
405 EYE IRRITATION 3 0.0001
406 LOWER LIMB FRACTURE 1 0.0001
407 GLAUCOMA 1 0.0001
408 EAR PAIN 1 0.0001
409 ARTHRALGIA 21 0.0001
410 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
411 SINUS DISORDER 1 0.0001
412 HAEMATOCRIT DECREASED 1 0.0001
413 BLOOD PRESSURE ABNORMAL 1 0.0001
414 PREGNANCY 1 0.0000
415 HYPOTENSION 10 0.0000
416 STOMATITIS 3 0.0000
417 ANXIETY 14 0.0000
418 DISCOMFORT 3 0.0000
419 OFF LABEL USE 42 0.0000
420 SEPTIC SHOCK 2 0.0000
421 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
422 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
423 CHROMATURIA 1 0.0000
424 INCORRECT DOSE ADMINISTERED 10 0.0000
425 PERICARDIAL EFFUSION 1 0.0000
426 COMA 2 0.0000
427 PRODUCTIVE COUGH 2 0.0000
428 GAIT DISTURBANCE 8 0.0000
429 ABDOMINAL DISCOMFORT 7 0.0000
430 CONTUSION 4 0.0000
431 MENTAL IMPAIRMENT 1 0.0000
432 PRESYNCOPE 1 0.0000
433 NEURALGIA 1 0.0000
434 CEREBRAL INFARCTION 1 0.0000
435 ENCEPHALOPATHY 1 0.0000
436 ABASIA 1 0.0000
437 DYSGEUSIA 3 0.0000
438 HYPOPHAGIA 1 0.0000
439 UNRESPONSIVE TO STIMULI 1 0.0000
440 EXPOSURE VIA SKIN CONTACT 1 0.0000
441 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
442 GASTRITIS 1 0.0000
443 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
444 PLATELET COUNT DECREASED 4 0.0000
445 PRODUCT USE ISSUE 7 0.0000
446 DRUG INEFFECTIVE 49 0.0000
447 DISTURBANCE IN ATTENTION 2 0.0000
448 PNEUMONITIS 1 0.0000
449 MOOD ALTERED 1 0.0000
450 SKIN LESION 1 0.0000
451 VISION BLURRED 5 0.0000
452 FATIGUE 28 0.0000
453 URTICARIA 6 0.0000
454 DEMENTIA 1 0.0000
455 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
456 ASTHMA 4 0.0000
457 PAIN IN JAW 1 0.0000
458 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
459 RED BLOOD CELL COUNT DECREASED 1 0.0000
460 ANGINA PECTORIS 1 0.0000
461 HYPERSOMNIA 1 0.0000
462 HERPES ZOSTER 2 0.0000
463 BALANCE DISORDER 3 0.0000
464 SEIZURE 4 0.0000
465 DYSSTASIA 1 0.0000
466 DYSPHONIA 2 0.0000
467 ASCITES 1 0.0000
468 WHEEZING 2 0.0000
469 DYSPNOEA 19 0.0000
470 BLOOD POTASSIUM DECREASED 1 0.0000
471 HEPATIC FAILURE 1 0.0000
472 APHASIA 1 0.0000
473 PLEURAL EFFUSION 2 0.0000
474 BREAST CANCER 3 0.0000
475 MOVEMENT DISORDER 1 0.0000
476 HIP FRACTURE 1 0.0000
477 DEEP VEIN THROMBOSIS 2 0.0000
478 AMNESIA 2 0.0000
479 BLOOD CREATININE INCREASED 2 0.0000
480 IMPAIRED HEALING 1 0.0000
481 OSTEONECROSIS 1 0.0000
482 LIP SWELLING 1 0.0000
483 FUNGAL INFECTION 1 0.0000
484 SYNCOPE 3 0.0000
485 SKIN DISORDER 1 0.0000
486 GAIT INABILITY 1 0.0000
487 MYALGIA 5 0.0000
488 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
489 CHEST DISCOMFORT 3 0.0000
490 NIGHTMARE 1 0.0000
491 DELIRIUM 1 0.0000
492 HYPERTENSION 6 0.0000
493 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
494 CEREBRAL HAEMORRHAGE 1 0.0000
495 OVERDOSE 6 0.0000
496 PANIC ATTACK 1 0.0000
497 ACCIDENTAL OVERDOSE 1 0.0000
498 EYE SWELLING 1 0.0000
499 DYSARTHRIA 1 0.0000
500 CHILLS 3 0.0000
501 DISEASE PROGRESSION 3 0.0000
502 RASH 11 0.0000
503 CARDIAC FAILURE 2 0.0000
504 EXTRA DOSE ADMINISTERED 1 0.0000
505 DYSKINESIA 1 0.0000
506 BLINDNESS 1 0.0000
507 NEUTROPHIL COUNT DECREASED 1 0.0000
508 ABDOMINAL PAIN UPPER 5 0.0000
509 FALL 8 0.0000
510 CARDIO-RESPIRATORY ARREST 1 0.0000
511 SKIN EXFOLIATION 2 0.0000
512 DIARRHOEA 15 0.0000
513 MENTAL DISORDER 1 0.0000
514 RENAL FAILURE 3 0.0000
515 INSOMNIA 6 0.0000
516 THERAPY NON-RESPONDER 1 0.0000
517 NEUTROPENIA 3 0.0000
518 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
519 SKIN IRRITATION 1 0.0000
520 NEPHROLITHIASIS 1 0.0000
521 BACK PAIN 5 0.0000
522 FEELING ABNORMAL 5 0.0000
523 PRURITUS 8 0.0000
524 DRUG INTOLERANCE 2 0.0000
525 HYPOGLYCAEMIA 1 0.0000
526 ATRIAL FIBRILLATION 2 0.0000
527 CELLULITIS 1 0.0000
528 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
529 HOSPITALISATION 3 0.0000
530 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
531 INFLAMMATION 1 0.0000
532 PANCREATITIS 1 0.0000
533 OEDEMA 1 0.0000
534 TREATMENT NONCOMPLIANCE 1 0.0000
535 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
536 ARTHROPATHY 1 0.0000
537 WEIGHT INCREASED 4 0.0000
538 BLISTER 1 0.0000
539 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
540 MYOCARDIAL INFARCTION 3 0.0000
541 BONE PAIN 1 0.0000
542 PAIN IN EXTREMITY 5 0.0000
543 JOINT SWELLING 2 0.0000
544 EMOTIONAL DISTRESS 2 0.0000
545 CONDITION AGGRAVATED 5 0.0000
546 FEELING HOT 1 0.0000
547 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
548 NASOPHARYNGITIS 3 0.0000
549 HYPERSENSITIVITY 3 0.0000
550 RHINORRHOEA 1 0.0000
551 PNEUMONIA 5 0.0000
552 PRODUCT DOSE OMISSION 1 0.0000
553 DRY SKIN 2 0.0000
554 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
555 MEMORY IMPAIRMENT 2 0.0000
556 DEVICE MALFUNCTION 1 0.0000
557 INJURY 1 0.0000
558 SLEEP DISORDER 1 0.0000
559 SKIN BURNING SENSATION 1 0.0000
560 INFECTION 2 0.0000
561 RESPIRATORY FAILURE 1 0.0000
562 PRODUCT DOSE OMISSION ISSUE 4 0.0000
563 UNEVALUABLE EVENT 1 0.0000
564 ACUTE KIDNEY INJURY 2 0.0000
565 DECREASED APPETITE 3 0.0000
566 ARTHRITIS 1 0.0000
567 PARAESTHESIA 2 0.0000
568 THROMBOSIS 1 0.0000
569 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
570 DIZZINESS 6 0.0000
571 DRUG ABUSE 1 0.0000
572 URINARY TRACT INFECTION 2 0.0000
573 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
574 NO ADVERSE EVENT 2 0.0000
575 SUICIDAL IDEATION 1 0.0000
576 MUSCLE SPASMS 2 0.0000
577 CHEST PAIN 2 0.0000
578 ASTHENIA 4 0.0000
579 BLOOD GLUCOSE INCREASED 2 0.0000
580 DYSPHAGIA 1 0.0000
581 PULMONARY EMBOLISM 1 0.0000
582 NEUROPATHY PERIPHERAL 1 0.0000
583 HEART RATE INCREASED 1 0.0000
584 FLUSHING 1 0.0000
585 SINUSITIS 1 0.0000
586 HAEMOGLOBIN DECREASED 1 0.0000
587 ILLNESS 1 0.0000
588 THROMBOCYTOPENIA 1 0.0000
589 DEPRESSION 2 0.0000
590 VISUAL IMPAIRMENT 1 0.0000
591 PRODUCT QUALITY ISSUE 1 0.0000
592 HYPOAESTHESIA 1 0.0000
593 VOMITING 3 0.0000
594 DRUG DEPENDENCE 1 0.0000
595 DRUG DOSE OMISSION 1 0.0000
596 TREMOR 1 0.0000
597 CEREBROVASCULAR ACCIDENT 1 0.0000
598 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
599 INJECTION SITE PAIN 1 0.0000
600 DEATH 1 0.0000